eXIthera

0 followers


eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation, preventing thrombosis without an increased risk of bleeding.

Org chart

Neil J. Hayward
CEO, President, & Co-Founder

Neil J. Hayward

Collapse
Michael Kurz
VP, Translational Medicine & Medical Affairs
Paula M. Bokesch
Head, Clinical Development
Bert L. Chenard
Head, Chemistry
Priya Jambhekar
Head, Regulatory Affairs
Andy Hu
Head, Corporate & Business Development
William Koster
Director (Chairman)